150 related articles for article (PubMed ID: 20564150)
61. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
Maini CL; Scelsa MG; Fiumara C; Tofani A; Sciuto R; Tipaldi L; D'Annibale M; Santoro E
Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
[TBL] [Abstract][Full Text] [Related]
62. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
63. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
[TBL] [Abstract][Full Text] [Related]
64. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
65. Adjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial.
Dumortier J; Decullier E; Hilleret MN; Bin-Dorel S; Valette PJ; Boillot O; Partensky C; Letoublon C; Ducerf C; Leroy V; Vuillez JP; Borson-Chazot F
J Nucl Med; 2014 Jun; 55(6):877-83. PubMed ID: 24722530
[TBL] [Abstract][Full Text] [Related]
66. Comparative survival analysis of adjuvant therapy with iodine-131-labeled lipiodol to hepatic resection of primary hepatocellular carcinoma: a meta-analysis.
Gong L; Shi L; Sun J; Yuan WS; Chen JF; Liu P; Gong F; Dong JH
Nucl Med Commun; 2014 May; 35(5):484-92. PubMed ID: 24492679
[TBL] [Abstract][Full Text] [Related]
67. 131I-Labelled-iodized oil for palliative treatment of hepatocellular carcinoma.
Borbath I; Lhommel R; Bittich L; Goffette P; Annet L; Van Beers BE; Bonny MA; Pauwels S; Horsmans Y
Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):905-10. PubMed ID: 16093866
[TBL] [Abstract][Full Text] [Related]
68. [Severe ischemic necrotizing cholangitis after intra-arterial iodine 131-labeled Lipiodol as therapy for hepatocellular carcinoma].
Vergniol J; Dubuc J; Le Bail B; Drouillard J; Couzigou P; De Ledinghen V
Gastroenterol Clin Biol; 2004 Apr; 28(4):403-4. PubMed ID: 15146158
[No Abstract] [Full Text] [Related]
69. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.
Yumoto Y; Jinno K; Inatsuki S; Moriwaki S; Hanafusa T; Yumoto E; Shiota T; Higashi T; Koide N; Hada H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S128-36. PubMed ID: 1281043
[TBL] [Abstract][Full Text] [Related]
70. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
[TBL] [Abstract][Full Text] [Related]
71. Iodine-131-lipiodol therapy in hepatic tumours.
Ahmadzadehfar H; Sabet A; Wilhelm K; Biersack HJ; Risse J
Methods; 2011 Nov; 55(3):246-52. PubMed ID: 21664971
[TBL] [Abstract][Full Text] [Related]
72. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol).
Kobayashi H; Nakajo M; Yano T; Shimabukuro K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1176-8. PubMed ID: 3005962
[No Abstract] [Full Text] [Related]
73. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
74. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
75. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
Garin E; Rakotonirina H; Lejeune F; Denizot B; Roux J; Noiret N; Mesbah H; Herry JY; Bourguet P; Lejeune JJ
Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
[TBL] [Abstract][Full Text] [Related]
76. 131I lipiodol therapy for unresectable hepatocellular carcinoma.
Rindani RB; Hugh TJ; Roche J; Roach PJ; Smith RC
ANZ J Surg; 2002 Mar; 72(3):210-4. PubMed ID: 12071454
[TBL] [Abstract][Full Text] [Related]
77. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
[TBL] [Abstract][Full Text] [Related]
78. Radionuclide therapy of hepatocellular carcinoma.
Keng GH; Sundram FX
Ann Acad Med Singap; 2003 Jul; 32(4):518-24. PubMed ID: 12968558
[TBL] [Abstract][Full Text] [Related]
79. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
[TBL] [Abstract][Full Text] [Related]
80. Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: immediate and long-term results.
Kajiya Y; Kobayashi H; Nakajo M
Cardiovasc Intervent Radiol; 1993; 16(3):150-7. PubMed ID: 8392913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
